Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TAXUS ARRIVE: Taxus peri-approval registry: A multi-center safety surveillance program

Next Previous
X
Search
Trial Profile

TAXUS ARRIVE: Taxus peri-approval registry: A multi-center safety surveillance program

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms ARRIVE
  • Sponsors Boston Scientific Corporation

    • Most Recent Events

    • 17 Oct 2008 Two-year results from the diabetic subset analysis presented at the Cardiovascular Research Foundation's Transcatheter Cardiovascular Therapeutics symposium.
    • 13 May 2008 Pooled analysis of 2-year outcomes for 7,492 patients in the ARRIVE 1 and 2 registries reported at EuroPCR 2008.
    • 29 Mar 2008 Pooled analysis of 2-year outcomes for 7,033 patients in the ARRIVE 1 and 2 registries reported at SCAI-ACCi2 2008.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top